Advertisement

Annals of Surgical Oncology

, Volume 16, Issue 8, pp 2295–2299 | Cite as

Lymphatic Drainage Patterns in Breast Cancer Patients Who Previously Underwent Mantle Field Radiation

  • Iris M. C. van der Ploeg
  • Nicola S. Russell
  • Omgo E. Nieweg
  • Hester S. A. Oldenburg
  • Bin B. R. Kroon
  • Renato A. Valdés Olmos
  • Emiel J. T. Rutgers
Breast Oncology

Abstract

Background

Lymphatic drainage may change after radiation of a breast or its regional lymph node basins, and this may have implications for lymphatic mapping afterward. The aim of this study was to determine the lymphatic drainage patterns in breast cancer patients who had undergone mantle field radiation for Hodgkin’s lymphoma in the past.

Methods

Between January 1999 and November 2008, 22 breast cancer patients underwent a sentinel node procedure after previous mantle field radiation. Lymphatic drainage patterns were analyzed based on lymphoscintigraphy and sentinel node biopsy. The results were compared with the drainage patterns in patients without previous treatment from an earlier study.

Results

Sentinel nodes were found in the axilla in 19 patients (86%) and 9 patients (41%) also had drainage toward extra-axillary regions. Sentinel nodes were more often found outside the axilla compared to the patients in our earlier study (33%, P = 0.04), and the nonidentification rate was also higher (14% vs. 3%, P = 0.01). Sentinel nodes were involved in 5 patients (23%). These were harvested from the internal mammary chain in two of them. No lymph node recurrences were observed during a median follow-up time of 49 months.

Conclusion

Lymphatic mapping is feasible and yields a lymph node in 86% of the breast cancer patients after previous mantle field radiotherapy for Hodgkin’s lymphoma. Nonvisualization and extra-axillary nodes are more frequently encountered than in patients without a history of mantle field radiation. The finding of involved nodes suggests that sentinel node biopsy improves staging. Long-term follow-up will determine the sensitivity of the procedure in this specific situation.

Keywords

Breast Cancer Patient Sentinel Node Sentinel Node Biopsy Axillary Node Dissection Lymphatic Mapping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, et al. Long-term risk of second malignancy in survivors of Hodgkin’s disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487–97.PubMedGoogle Scholar
  2. 2.
    Van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, et al. Second cancer risk following Hodgkin’s disease: a 20-year follow-up study. J Clin Oncol. 1994;12:312–25.PubMedGoogle Scholar
  3. 3.
    Swerdlow AJ, Barber JA, Hudson GV, Cunningham D, Gupta RK, Hancock BW, et al. Risk of second malignancy after Hodgkin’s disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000;18:498–509.PubMedGoogle Scholar
  4. 4.
    Zijlstra JM, Dressel AJ, Mens JW, Tinteren H, Slotman BJ, Jonkhoff AR, et al. Radiation therapy in early stage Hodgkin’s disease: long-term results and adverse effects. Hematol J. 2002;3:179–84.PubMedCrossRefGoogle Scholar
  5. 5.
    Broeks A, Russell NS, Floore AN, Urbanus JH, Dahler EC, van Veer T, et al. Increased risk of breast cancer following irradiation for Hodgkin’s disease is not a result of ATM germline mutations. Int J Radiat Biol. 2000;76:693–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Wolden SL, Hancock SL, Carlson RW, Goffinet DR, Jeffrey SS, Hoppe RT. Management of breast cancer after Hodgkin’s disease. J Clin Oncol. 2000;18:765–72.PubMedGoogle Scholar
  7. 7.
    Tinger A, Wasserman TH, Klein EE, Miller EA, Roberts T, Piephoff JV, et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys. 1997;37:865–70.PubMedGoogle Scholar
  8. 8.
    Hancock SL, Tucker MA, Hoppe RT. Breast cancer after treatment of Hodgkin’s disease. J Natl Cancer Inst. 1993;85:25–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van’t Veer MB, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst. 2003;95:971–80.PubMedGoogle Scholar
  10. 10.
    Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 1990;19:1569–74.PubMedGoogle Scholar
  11. 11.
    Scharpfenecker M, Kruse JJ, Sprong D, Russell NS, Ten Dijke P, Stewart FA. Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. Int J Radiat Oncol Biol Phys. 2009;73:506–13.PubMedGoogle Scholar
  12. 12.
    Estourgie SH, Nieweg OE, Valdés Olmos RA, Rutgers EJ, Kroon BB. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Nieweg OE, Tanis PJ, Kroon BBR. The definition of a sentinel node. Ann Surg Oncol. 2001;8:538–41.PubMedCrossRefGoogle Scholar
  14. 14.
    Van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, Rutgers EJ, Kroon BB, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007;48:1756–60.PubMedCrossRefGoogle Scholar
  15. 15.
    Van der Ploeg IMC, Kroon BBR, Antonini N, Valdés Olmos RA, Rutgers EJ, Nieweg OE. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration. Ann Surg Oncol. 2008;15:1025–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.PubMedCrossRefGoogle Scholar
  17. 17.
    Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983–90.PubMedCrossRefGoogle Scholar
  18. 18.
    Krag DN. The sentinel node for staging breast cancer: Current review. Breast Cancer. 1999;6:233–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Nieweg OE, Jansen L, Valdés Olmos RA, Rutgers EJ, Peterse JL, Hoefnagel KA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med. 1999;26:S11–S16.PubMedCrossRefGoogle Scholar
  20. 20.
    Estourgie SH, Valdés Olmos RA, Nieweg OE, Hoefnagel CA, Rutgers EJ, Kroon BB. Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Br J Surg. 2007;94:1088–91.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2009

Authors and Affiliations

  • Iris M. C. van der Ploeg
    • 1
  • Nicola S. Russell
    • 2
  • Omgo E. Nieweg
    • 1
  • Hester S. A. Oldenburg
    • 1
  • Bin B. R. Kroon
    • 1
  • Renato A. Valdés Olmos
    • 3
  • Emiel J. T. Rutgers
    • 1
  1. 1.Department of SurgeryThe Netherlands Cancer Institute—Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  2. 2.Department of Radiation OncologyThe Netherlands Cancer Institute—Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands
  3. 3.Department of Nuclear MedicineThe Netherlands Cancer Institute—Antoni van Leeuwenhoek HospitalAmsterdamThe Netherlands

Personalised recommendations